These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

736 related articles for article (PubMed ID: 24507518)

  • 1. The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment.
    Robinson AP; Harp CT; Noronha A; Miller SD
    Handb Clin Neurol; 2014; 122():173-89. PubMed ID: 24507518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glatiramer acetate for treatment of MS: regulatory B cells join the cast of players.
    Van Kaer L
    Exp Neurol; 2011 Jan; 227(1):19-23. PubMed ID: 20969865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis.
    Steinman L; Zamvil SS
    Trends Immunol; 2005 Nov; 26(11):565-71. PubMed ID: 16153891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studies.
    Teitelbaum D; Aharoni R; Klinger E; Kreitman R; Raymond E; Malley A; Shofti R; Sela M; Arnon R
    Ann N Y Acad Sci; 2004 Dec; 1029():239-49. PubMed ID: 15681762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal Models of Multiple Sclerosis.
    Smith P
    Curr Protoc; 2021 Jun; 1(6):e185. PubMed ID: 34170637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulation neuroprotection and remyelination - the fundamental therapeutic effects of glatiramer acetate: a critical review.
    Aharoni R
    J Autoimmun; 2014 Nov; 54():81-92. PubMed ID: 24934599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
    Rostami A; Ciric B
    J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
    Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
    Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance.
    Salehipour Z; Haghmorad D; Sankian M; Rastin M; Nosratabadi R; Soltan Dallal MM; Tabasi N; Khazaee M; Nasiraii LR; Mahmoudi M
    Biomed Pharmacother; 2017 Nov; 95():1535-1548. PubMed ID: 28946394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis.
    Tuohy VK; Yu M; Yin L; Kawczak JA; Johnson JM; Mathisen PM; Weinstock-Guttman B; Kinkel RP
    Immunol Rev; 1998 Aug; 164():93-100. PubMed ID: 9795767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis.
    Kala M; Rhodes SN; Piao WH; Shi FD; Campagnolo DI; Vollmer TL
    Exp Neurol; 2010 Jan; 221(1):136-45. PubMed ID: 19879259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From classic to spontaneous and humanized models of multiple sclerosis: impact on understanding pathogenesis and drug development.
    Ben-Nun A; Kaushansky N; Kawakami N; Krishnamoorthy G; Berer K; Liblau R; Hohlfeld R; Wekerle H
    J Autoimmun; 2014 Nov; 54():33-50. PubMed ID: 25175979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cinnamon ameliorates experimental allergic encephalomyelitis in mice via regulatory T cells: implications for multiple sclerosis therapy.
    Mondal S; Pahan K
    PLoS One; 2015; 10(1):e0116566. PubMed ID: 25569428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental Autoimmune Encephalomyelitis (EAE) as Animal Models of Multiple Sclerosis (MS).
    Glatigny S; Bettelli E
    Cold Spring Harb Perspect Med; 2018 Nov; 8(11):. PubMed ID: 29311122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Multi-epitope-targeted' immune-specific therapy for a multiple sclerosis-like disease via engineered multi-epitope protein is superior to peptides.
    Kaushansky N; Kerlero de Rosbo N; Zilkha-Falb R; Yosef-Hemo R; Cohen L; Ben-Nun A
    PLoS One; 2011; 6(11):e27860. PubMed ID: 22140475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).
    Constantinescu CS; Farooqi N; O'Brien K; Gran B
    Br J Pharmacol; 2011 Oct; 164(4):1079-106. PubMed ID: 21371012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
    Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
    Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity.
    Weber MS; Prod'homme T; Patarroyo JC; Molnarfi N; Karnezis T; Lehmann-Horn K; Danilenko DM; Eastham-Anderson J; Slavin AJ; Linington C; Bernard CC; Martin F; Zamvil SS
    Ann Neurol; 2010 Sep; 68(3):369-83. PubMed ID: 20641064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope spreading occurs in active but not passive EAE induced by myelin basic protein.
    Voskuhl RR; Farris RW; Nagasato K; McFarland HF; Dalcq MD
    J Neuroimmunol; 1996 Nov; 70(2):103-11. PubMed ID: 8898718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent insights into the mechanism of action of glatiramer acetate.
    Kala M; Miravalle A; Vollmer T
    J Neuroimmunol; 2011 Jun; 235(1-2):9-17. PubMed ID: 21402415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.